XTCY — Xtacy Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.33m
- CA$2.34m
Annual cashflow statement for Xtacy Therapeutics, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.37 | -1.37 | -3.58 | -1.37 | -0.52 |
| Non-Cash Items | 1.06 | 1.28 | 2.98 | 0.287 | -0.403 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.05 | 0.031 | 0.502 | 0.656 | 0.842 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.36 | -0.061 | -0.098 | -0.426 | -0.081 |
| Other Investing Cash Flow Items | — | 0.047 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0.047 | 0 | — | — |
| Financing Cash Flow Items | -0.029 | 0 | 0.045 | 0 | 0.052 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.452 | 0 | 0.12 | 0.401 | 0.081 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.91 | -0.014 | 0.022 | -0.026 | 0 |